Show simple item record

Transcutaneous Electrical Nerve Stimulation to Improve Female Sexual Dysfunction Symptoms: A Pilot Study

dc.contributor.authorZimmerman, Lauren L.
dc.contributor.authorGupta, Priyanka
dc.contributor.authorO’Gara, Florence
dc.contributor.authorLanghals, Nicholas B.
dc.contributor.authorBerger, Mitchell B.
dc.contributor.authorBruns, Tim M.
dc.date.accessioned2018-11-20T15:35:48Z
dc.date.available2019-12-02T14:55:09Zen
dc.date.issued2018-10
dc.identifier.citationZimmerman, Lauren L.; Gupta, Priyanka; O’Gara, Florence; Langhals, Nicholas B.; Berger, Mitchell B.; Bruns, Tim M. (2018). "Transcutaneous Electrical Nerve Stimulation to Improve Female Sexual Dysfunction Symptoms: A Pilot Study." Neuromodulation: Technology at the Neural Interface 21(7): 707-713.
dc.identifier.issn1094-7159
dc.identifier.issn1525-1403
dc.identifier.urihttps://hdl.handle.net/2027.42/146481
dc.publisherJohn Wiley & Sons, Inc.
dc.subject.otherelectrical stimulation
dc.subject.otherfemale sexual dysfunction
dc.subject.othergenital arousal
dc.subject.otherposterior tibial nerve
dc.subject.otherDorsal genital nerve
dc.titleTranscutaneous Electrical Nerve Stimulation to Improve Female Sexual Dysfunction Symptoms: A Pilot Study
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelNeurology and Neurosciences
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/146481/1/ner12846.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/146481/2/ner12846_am.pdf
dc.identifier.doi10.1111/ner.12846
dc.identifier.sourceNeuromodulation: Technology at the Neural Interface
dc.identifier.citedreferenceRosen R, Brown C, Heiman J, Leiblum S. The Female Sexual Function Index (FSFI): a multidimensional self‐report instrument for the assessment of female sexual function. J Sex Marital Ther 2000; 26: 37 – 41.
dc.identifier.citedreferenceParnell BA, Howard JF, Geller EJ. The effect of sacral neuromodulation on pudendal nerve function and female sexual function. Neurourol Urodyn 2015; 34: 456 – 460.
dc.identifier.citedreferencevan Balken MR, Verguns H, Bemelmans BLH. Sexual functioning in patients with lower urinary tract dysfunction improves after percutaneous tibial nerve stimulation. Int J Impot Res 2006; 18: 470 – 475.
dc.identifier.citedreferenceGokyildiz S, Beji NK, Yalcin O, Istek A. Effects of percutaneous tibial nerve stimulation therapy on chronic pelvic pain. Gynecol Obstet Invest 2012; 73: 99 – 105.
dc.identifier.citedreferenceMusco S, Serati M, Lombardi G et al. Percutaneous tibial nerve stimulation improves female sexual function in women with overactive bladder syndrome. J Sex Med 2016; 13: 238 – 242.
dc.identifier.citedreferenceCoyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well‐being in men and women: results from the EPIC study. BJU Int 2008; 101: 1388 – 1395.
dc.identifier.citedreferenceSalonia A, Zanni G, Nappi RE et al. Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross‐sectional study. Eur Urol 2004; 45: 642 – 648.
dc.identifier.citedreferenceIsidori AM, Pozza C, Esposito K et al. Development and validation of a 6‐item version of the female sexual function index (FSFI) as a diagnostic tool for female sexual dysfunction. J Sex Med 2010; 7: 1139 – 1146.
dc.identifier.citedreferenceWorsøe J, Fynne L, Laurberg S, Krogh K, Rijkhoff NJM. The acute effect of dorsal genital nerve stimulation on rectal wall properties in patients with idiopathic faecal incontinence. Color Dis 2011; 13: 462 – 466.
dc.identifier.citedreferenceGaziev G, Topazio L, Iacovelli V et al. Percutaneous tibial nerve stimulation (PTNS) efficacy in the treatment of lower urinary tract dysfunctions: a systematic review. BMC Urol 2013; 13: 61.
dc.identifier.citedreferenceWare JE, Sherbourne C. The MOS 36‐Item Short‐Form Health Survey (SF‐36) conceptual framework and item selection. Med Care 1992; 30: 473 – 483.
dc.identifier.citedreferenceScarpero HM, Fiske J, Xue X, Nitti VW. American urological association symptom index for lower urinary tract symptoms in women: correlation with degree of bother and impact on quality of life. Urology 2003; 61: 1118 – 1122.
dc.identifier.citedreferenceHurst H, Bolton J. Assessing the clinical significance of change scores recorded on subjective outcome measures. J Manipulative Physiol Ther 2004; 27: 26 – 35.
dc.identifier.citedreferenceHarris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research Electronic Data Capture (REDCap): a metadata driven methodology and workflow process for providing translational research informatict support. J Biomed Inform 2009; 42: 377 – 381.
dc.identifier.citedreferenceWiegel M, Meston C, Rosen R. The Female Sexual Function Index (FSFI): cross‐validation and development of clinical cutoff scores. J Sex Marital Ther 2005; 31: 1 – 20.
dc.identifier.citedreferenceYoong W, Shah P, Dadswell R, Green L. Sustained effectiveness of percutaneous tibial nerve stimulation for overactive bladder syndrome: 2‐year follow‐up of positive responders. Int Urogynecol J Pelvic Floor Dysfunct 2013; 24: 795 – 799.
dc.identifier.citedreferenceClayton AH, Althof SE, Kingsberg S et al. Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo‐controlled dose‐finding trial. Womens Health (Lond Engl) 2016; 12: 325 – 337.
dc.identifier.citedreferenceSignorello D, Seitz CC, Berner L et al. Impact of sacral neuromodulation on female sexual function and his correlation with clinical outcome and quality of life indexes: a monocentric experience. J Sex Med 2011; 8: 1147 – 1155.
dc.identifier.citedreferenceBoth S, Paul K, Olaf E. Sexual response in women with type 1 diabetes mellitus: a controlled laboratory study measuring vaginal blood flow and subjective sexual arousal. Arch Sex Behav 2015; 44: 1573 – 1587.
dc.identifier.citedreferenceCramp JD, Courtois FJ, Ditor DS. Sexuality for women with spinal cord injury. J Sex Marital Ther 2015; 41: 238 – 253.
dc.identifier.citedreferenceRice IC, Zimmerman LL, Ross SE, Berger MB, Bruns TM. Time‐frequency analysis of increases in vaginal blood perfusion elicited by long‐duration pudendal neuromodulation in anesthetized rats. Neuromodulation 2017; 20: 807 – 815.
dc.identifier.citedreferenceZimmerman LL, Rice IC, Berger MB, Bruns TM. Tibial nerve stimulation to drive genital sexual arousal in an anesthetized female rat. J Sex Med 2018; 15: 296 – 303.
dc.identifier.citedreferenceAmmi M, Chautard D, Brassart E, Culty T, Azzouzi AR, Bigot P. Transcutaneous posterior tibial nerve stimulation: evaluation of a therapeutic option in the management of anticholinergic refractory overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct 2014; 25: 1065 – 1069.
dc.identifier.citedreferenceBooth J, Hagen S, McClurg D et al. A feasibility study of transcutaneous posterior tibial nerve stimulation for bladder and bowel dysfunction in elderly adults in residential care. J Am Med Dir Assoc 2013; 14: 270 – 274.
dc.identifier.citedreferenceLaumann EO, Paik A, Rosen RC, Page P. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999; 281: 537 – 545.
dc.identifier.citedreferenceShifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol 2008; 112: 970 – 978.
dc.identifier.citedreferenceLewis RW, Fugl‐Meyer KS, Corona G et al. Definitions/Epidemiology/Risk factors for sexual dysfunction. J Sex Med 2010; 7: 1598 – 1607.
dc.identifier.citedreferenceLevin RJ, Both S, Georgiadis J, Kukkonen T, Park K, Yang CC. The physiology of female sexual function and the pathophysiology of female sexual dysfunction (Committee 13A). J Sex Med 2016; 13: 733 – 759.
dc.identifier.citedreferenceClayton AH, Valladares Juarez EM. Female sexual dysfunction. Psychiatr Clin North Am 2017; 40: 267 – 284.
dc.identifier.citedreferenceCenter for Drug Evaluation and Research & U.S. Food and Drug Administration. The voice of the patient: female sexual dysfunction. http://www.fda.gov/downloads/Drugs/NewsEvents/UCM453718.pdf
dc.identifier.citedreferenceAllahdadi KJ, Tostes RCA, Webb RC. Female sexual dysfuction: Therapeutic options and experimental challenges. Cardiovasc Hematol Agents Med Chem 2009; 7: 260 – 269.
dc.identifier.citedreferenceKatz M, Derogatis LR, Ackerman R et al. Efficacy of flibanserin in women with hypoactive sexual desire disorder: Results from the BEGONIA trial. J Sex Med 2013; 10: 1807 – 1815.
dc.identifier.citedreferencePortman DJ, Brown L, Yuan J, Kissling R, Kingsberg SA. Flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the PLUMERIA study. J Sex Med 2017; 14: 834 – 842.
dc.identifier.citedreferenceCavalcanti AL, Bagnoli VR, Fonseca ÂM et al. Effect of sildenafil on clitoral blood flow and sexual response in postmenopausal women with orgasmic dysfunction. Int J Gynecol Obstet 2008; 102: 115 – 119.
dc.identifier.citedreferenceBasson R, McInnes R, Smith MD, Hodgson G, Koppiker N. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J Womens Health Gend Based Med 2002; 11: 367 – 377.
dc.identifier.citedreferenceGupta P, Ehlert MJ, Sirls LT, Peters KM. Percutaneous tibial nerve stimulation and sacral neuromodulation: an update. Curr Urol Rep 2015; 16: 4 – 9.
dc.identifier.citedreferenceVodusek DJ, Light JK, Libby JM. Detrusor inhibition induced by stimulation of pudendal nerve afferents. Neurourol Urodyn 1986; 5: 381 – 389.
dc.identifier.citedreferencePrevinaire JG, Soler JM, Boileau G et al. Short‐term effect of pudendal nerve electrical stimulation on destrusor hyperreflexia in spinal cord injury patients: importance of current strength. Int Med Soc Paraplegia 1996; 34: 95 – 99.
dc.identifier.citedreferenceOpisso E, Borau A, Rijkhoff NJM. Subject‐controlled stimulation of dorsal genital nerve to treat neurogenic detrusor overactivity at home. Neurourol Urodyn 2013; 32: 1004 – 1009.
dc.identifier.citedreferenceGoldman HB, Amundsen CL, Mangel J et al. Dorsal genital nerve stimulation for the treatment of overactive bladder symptoms. Neurourol Urodyn 2008; 27: 499 – 503.
dc.identifier.citedreferencePeters KM, Carrico DJ, Perez‐marrero RA et al. Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol 2010; 183: 1438 – 1443.
dc.identifier.citedreferenceMoossdorff‐Steinhauser HFA, Berghmans B. Effects of percutaneous tibial nerve stimulation on adult patients with overactive bladder syndrome: a systematic review. Neurourol Urodyn 2013; 32: 206 – 214.
dc.identifier.citedreferencevan Breda HMK, Heesakkers JPFA. Neuromodulation for voiding dysfunction: when and how best to use. Curr Bladder Dysfunct Rep 2014; 9: 41 – 47.
dc.identifier.citedreferenceMcGuire E, Zhang S, Horwinski E, Lytton B. Treatment of motor and sensory detrusor instability by electrical stimulation. J Urol 1983; 129: 78 – 79.
dc.identifier.citedreferenceAmarenco G, Ismael SS, Even‐Schneider A et al. Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder. J Urol 2003; 169: 2210 – 2215.
dc.identifier.citedreferenceAndrews BJ, Reynard JM. Transcutaneous posterior tibial nerve stimulation for treatment of detrusor hyperreflexia in spinal cord injury. J Urol 2003; 170: 926.
dc.identifier.citedreferenceTai C, Shen B, Chen M, Wang J, Roppolo JR, de Groat WC. Prolonged poststimulation inhibition of bladder activity induced by tibial nerve stimulation in cats. Am J Physiol Ren Physiol 2011; 300: F385 – F392.
dc.identifier.citedreferenceLombardi G, Mondaini N, Macchiarella A, Cilotti A, Popolo GD. Clinical female sexual outcome after sacral neuromodulation implant for lower urinary tract symptom (LUTS). J Sex Med 2008; 5: 1411 – 1417.
dc.identifier.citedreferenceGill BC, Swartz MA, Firoozi F et al. Improved sexual and urinary function in women with sacral nerve stimulation. Neuromodulation 2011; 14: 436 – 443.
dc.identifier.citedreferenceYih JM, Killinger KA, Boura JA, Peters KM. Changes in sexual functioning in women after neuromodulation. J Sex Med 2013; 10: 2477 – 2483.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.